Focal adhesion protein expression in human diffuse large B-cell lymphoma


Por: Bosch, R, Dieguez-Gonzalez, R, Moreno, MJ, Gallardo, A, Novelli, S, Espinosa, I, Cespedes, MV, Pavon, MA, Briones, J, Granena, A, Sierra, J, Mangues, R, Casanova, I

Publicada: 1 jul 2014
Resumen:
Aims: Focal adhesions have been associated with poor prognosis in multiple cancer types, but their prognostic value in diffuse large B-cell lymphoma (DLBCL) has not been evaluated. The aim of this study was to investigate the expression patterns and the prognostic value of the focal adhesion proteins FAK, Pyk2, p130Cas and HEF1 in DLBCL. Methods and results: Focal adhesion protein expression was examined using immunohistochemistry in normal lymphoid tissues and in 60 DLBCL patient samples. Kaplan-Meier survival and Cox regression analysis were performed to evaluate the correlation of focal adhesion protein expression with patient prognosis. FAK, Pyk2, p130Cas and HEF1 expression was mostly found in the germinal centres of normal human lymphoid tissues. When assessed in DLBCL samples, FAK, Pyk2, p130Cas and HEF1 were highly expressed in 45%, 34%, 42% and 45% of the samples, respectively. Multivariate Cox analysis revealed that decreased FAK expression was a significant independent predictor of poorer disease outcome. Conclusions: FAK expression is an independent prognostic factor in DLBCL. Our results suggest that the addition of FAK immunostaining to the current immunohistochemical algorithms may facilitate risk stratification of DLBCL patients.

Filiaciones:
Bosch, R:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

Dieguez-Gonzalez, R:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

Moreno, MJ:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

Gallardo, A:
 Clin Girona, Dept Pathol, Girona, Spain

Novelli, S:
 Hosp Santa Creu & Sant Pau, Dept Haematol, Barcelona, Spain

 Red Temat Invest Cooperat Canc RETICC, Barcelona, Spain

Espinosa, I:
 Red Temat Invest Cooperat Canc RETICC, Barcelona, Spain

 Hosp Sant Creu & St Pau, Dept Pathol, Barcelona, Spain

Cespedes, MV:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

 CIBER BBN, Barcelona, Spain

Pavon, MA:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

Briones, J:
 Hosp Santa Creu & Sant Pau, Dept Haematol, Barcelona, Spain

 Red Temat Invest Cooperat Canc RETICC, Barcelona, Spain

Granena, A:
 Hosp Univ Bellvitge, Dept Haematol, Barcelona, Spain

Sierra, J:
 Hosp Santa Creu & Sant Pau, Dept Haematol, Barcelona, Spain

 Red Temat Invest Cooperat Canc RETICC, Barcelona, Spain

Mangues, R:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

 CIBER BBN, Barcelona, Spain

Casanova, I:
 Inst Invest Biomed St Pau, GOA, Barcelona 08028, Spain

 CIBER BBN, Barcelona, Spain
ISSN: 03090167





HISTOPATHOLOGY
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 65 Número: 1
Páginas: 119-131
WOS Id: 000337694700013
ID de PubMed: 24467224

MÉTRICAS